Cargando…
Measuring the impact of monoclonal antibody therapies
OBJECTIVE: Monoclonal antibody (Mab) treatments have significantly improved the quality and quantity of life, but they are some of the most expensive treatments, resulting in a degree of hesitancy to introduce new Mab agents. A system for estimating the effect of Mab drugs, in general, would optimal...
Autores principales: | Lim, Ka Keat, Ng, Kenrick, Balachandran, Sathiyaa, Russell, Mark D., Boalch, Amy, Sinclair, Alasdair, Coker, Bolaji, Vinnakota, Krishna, Mansoor, Rashid, Douiri, Abdel, Marks, Lara V., Sacks, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690588/ https://www.ncbi.nlm.nih.gov/pubmed/38046416 http://dx.doi.org/10.3389/fmed.2023.1256712 |
Ejemplares similares
-
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020) -
Diagnosing Camurati–Engelmann disease—the age of whole-exome sequencing
por: Nagra, Deepak, et al.
Publicado: (2022) -
Impact of hospital mergers on staff job satisfaction: a quantitative study
por: Lim, Ka Keat
Publicado: (2014) -
COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort
por: Adas, Maryam A, et al.
Publicado: (2023) -
Specialist follow-up contraceptive support after abortion—Impact on effective contraceptive use at six months and subsequent abortions: A randomised controlled trial
por: Kumar, Usha, et al.
Publicado: (2019)